FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072254 [Registered on: 09/08/2024] Trial Registered Prospectively
Last Modified On: 05/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Radiation Therapy 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A STUDY TO COMPARE THE EFFICACY OF THREE DIFFERENT DOSE FRACTIONATION REGIMENS IN PALLIATIVE RADIOTHERAPY FOR PATIENTS WITH PAINFUL BONE METASTASIS A study to compare the efficacy of three different dose fractionation regimens in palliative radiotherapy for patients with painful bone metastasis. 
Scientific Title of Study   A prospective randomized study to compare the efficacy of three different dose fractionation regimens in palliative radiotherapy for patients with painful bone metastasis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  G Sindhu 
Designation  Junior resident MD Radiotherapy 
Affiliation  Sri venkateswara institute of medical sciences tirupati 
Address  DEPARTMENT OF RADIATION ONCOLOGY SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, TIRUPATI Department of radiation oncology ,Sri Venkateswara institute of medical sciences, Tirupati

Chittoor
ANDHRA PRADESH
517507
India 
Phone  7995115063  
Fax    
Email  sindhugongada@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pranabandhu das  
Designation  Professor, MD Radiotherapy 
Affiliation  Sri venkateswara institute of medical sciences tirupati 
Address  DEPARTMENT OF RADIATION ONCOLOGY SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, TIRUPATI Department of radiation oncology,Sri Venkateswara institute of medical sciences ,Tirupati

Chittoor
ANDHRA PRADESH
517507
India 
Phone  9493547731  
Fax    
Email  daspranabandhu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  G Sindhu 
Designation  Junior resident MD Radiotherapy 
Affiliation  Sri venkateswara institute of medical sciences tirupati 
Address  DEPARTMENT OF RADIATION ONCOLOGY SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, TIRUPATI Department of radiation oncology, Sri Venkateswara institute of medical sciences

Chittoor
ANDHRA PRADESH
517507
India 
Phone  7995115063  
Fax    
Email  sindhugongada@gmail.com  
 
Source of Monetary or Material Support  
SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, TIRUPATI ,CHITTOOR DISTRICT, ANDHRA PRADESH,517507  
 
Primary Sponsor  
Name  Sri Venkateshwara Institute of medical sciences  
Address  Department of radiation oncology, Sri Venkateswara institute of medical sciences, Tirupati,517507  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
G Sindhu  Sri venkateswara institute of medical sciences   Department of radiation oncology Sri Venkateswara institute of medical sciences , Tirupati,517507
Chittoor
ANDHRA PRADESH 
7995115063

sindhugongada@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee of SVIMS   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C795||Secondary malignant neoplasm of bone and bone marrow,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Assessment of pain among 3 different treatment schedules  Pain score among 3 different treatment schedules 8Gy in 1# 20Gy in 5# 30Gy in 10# 
Intervention  Radiation therapy to bone metastasis using 3 different treatment schedules  Dose of 8Gy in 1 fraction, Dose of 20 Gy in 5 fractions, Dose of 30 Gy in 10 fractions 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1.Radiologically evident bone metastases from any primary tumor site.

2.Patients with pain due to bone metastasis

3.Patients with uncomplicated bone pain

4.ECOG performance status 0-3

5.Patients who have given informed consent

6.Patients of age 18yrs or older
 
 
ExclusionCriteria 
Details  1.Previous history of radioisotope treatment

2.Previous surgical intervention to same location

3.Patients with pathological fracture

4.Pregnant and lactating women
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Pain score assessment will be done among patients receiving 3 different treatment schedules during the course of treatment, at 1 month ,2 months and 3 months of follow up   1 month, 2 months, 3 months  
 
Secondary Outcome  
Outcome  TimePoints 
1.To determine the analgesic requirement by using narcotic score .

2.To determine the improvement in performance status by using ECOG

3.To determine improvement in quality of life by using BOMET-QOL questionnaire  
every month for 3 months after completion of treatment  
 
Target Sample Size   Total Sample Size="195"
Sample Size from India="195" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM

 

To compare the efficacy of three different fractionation regimens like 8GY / single fraction , 20GY/ 5 fractions, 30GY/10 fractions with palliative radiotherapy for patients with symptomatic bone metastases

OBJECTIVES

           PRIMARY OBECTIVE

1.     To determine the duration of pain relief by using pain score 

 

SECONDARY OBJECTIVE

1.      To determine the analgesic requirement by using narcotic score 

2.      To determine the improvement in performance status by using ECOG 

3.      To determine improvement in quality of life by using BOMET-QOL questionnaire 

MATERIALS AND METHODS:

 

TYPE OF STUDY:A prospective randomized control study

INCLUSION CRITERIA :

1.      Radiologically  evident  bone metastases from any primary tumor site.

2.      Patients with pain due to bone metastasis

3.      Patients with uncomplicated bone pain

4.      ECOG performance status 0-3

5.      Patients who have given informed consent

6.      Patients of age 18yrs or older

EXCLUSION CRITERIA:

1.      Previous history of radioisotope treatment

2.      Previous surgical intervention to same location

3.      Patients with pathological fracture

4.      Pregnant and lactating women

SELECTION OF PATIENT: 

The study will be conducted on patients with bone metastasis who is satisfying inclusion criteria presenting to radiation oncology OPD at SVIMS  Tirupati

STUDY PERIOD

18 months from the date of IEC approval.

SAMPLE SIZE

The number of subjects required in ARM A, ARM B & ARM C was calculated to be 65 in each group . Hence total sample size is 195 subjects .

But the patients who satisfy inclusion criteria during the specified time period will only be included or atleast 30 patients in each arm as appropriate .

REGULATORY APPROVALS

The study has been approved by Institutional Thesis Protocol Approval Committee 9 roc No. AS/12/TPAC/SVIMS/2017)(TPAC No. 822, dated 25.04.24) and Institutional Ethics committee ( Roc No. AS /11/IEC/SVIMS/2017) dated 24.06.24. The study will be registered at Clinical Trial Registry India (CTRI)

INFORMED CONSENT:

 A written informed consent will be obtained from all patients participating in the study.

RADIOTHERAPY TECHNIQUE:

After randomization patient immobilization will be done based on the location of bone metastasis.

Patients  will undergo simulation on a SEIMENS CT (somatom definition AS, 80 cm bore size, Berlin, Munich-Germany) machine dedicated to radiotherapy treatment simulation in our institute.

CT images will be acquired in 3mm slice thickness and will be transferred to treatment planning system [Varian/Oncentra 4.3]

Planning will be done by 3DCRT technique

GTV, CTV, PTVand OARS will be contoured as per

GTV – clinically and radiologically identifiable bone lesions

CTV – GTV and areas harboring microscopic disease

PTV – CTV and a margin for set up errors and normal physiological movement of organs

Planning will be done on Oncentra/Eclipse treatment planning system such that PTV should get 95 -107% of total prescribed dose and normal tissue doses tolerance being respected.

Based on the randomization patients will receive 8Gy in single fraction or 20 Gy in 5 fractions or 30Gy in 10 fractions 

EVALUATION OF PATIENT:

Patients will be evaluated for pain severity and frequency with pain score

Patients will also be evaluated for analgesic use before and after treatment

Pain assessmentand  evaluation of analgesic usage will be done on the day of treatment, followed by daily during the course of treatment and then monthly after completion of RT for 3 months.

PAIN SCALE

Visual analogue scales (VAS)

The VAS is an unmarked line with extremes marked as no pain and worst pain.

Patients are asked to mark the point in the line that describes their pain.

Categorical verbal rating scales (VRS) -- 4 point scale 

A VRS involves a sequence of words describing different intensity levels of pain

such as:

  0-None

1-3  Mild

  4-7 Moderate

  8-10 Severe.

 

Evaluation of analgesic usage

Analgesic requirement was graded according to type of analgesic needed for pain relief, as:

0 = not requiring any analgesics;

1 = simple analgesics such as non-steroidal anti-inflammatory drugs (NSAIDS);

2 = mild narcotics (codeine, tramadol);

3 = strong narcotics (morphine, fentanyl);

4 = high dose narcotics inadequate.

Improvement in performance status was defined as a decrease in ECOG functional outcome score by at least one grade with respect to pre-treatment value.

STATISTICAL ANALYSIS

 

Study parameters data will be recorded on a predesigned study proforma and then entered in Microsoft office Excel and data studied by SPSS (26.0 V) version. Data will be summarised using number and percentage for qualitative +/- standard deviation.

  • Association between any two categorical variables will be analysed using Chi square test.
  • P value less than 0.05 indicates that there is an association between the two groups & the categorical variable.
  • Statistically significant difference among the two groups with respect to any continuous variable will be analysed using sample T test.

·         P value less than 0.05 indicates that there is a significant difference between the mean values among the two groups with respect to that variable

 




 
Close